Injective (INJ) is a layer-one blockchain designed to support the development of decentralized finance (DeFi) applications, including decentralized spot and derivatives exchanges, prediction markets, and lending protocols. It offers foundational financial infrastructure like a fully decentralized on-chain order book, aiming to support various financial markets such as spot, perpetual, futures, and options—all executed fully on-chain. Injective is compatible with Ethereum, IBC-enabled blockchains, and non-EVM chains like Solana. Built using the Cosmos SDK, it employs a Tendermint-based Proof-of-Stake consensus mechanism, which strives to deliver instant transaction finality and high performance.

Injective utilizes a Tendermint-based Proof-of-Stake consensus mechanism, enabling fast transaction finality and maintaining high network performance. It incorporates a decentralized cross-chain bridging infrastructure that supports compatibility with Ethereum, IBC-enabled chains, and non-EVM blockchains like Solana. Injective's core exchange module features an advanced on-chain order book and matching engine for spot, perpetual, futures, and options markets. It aims to reduce Miner-Extractable Value (MEV) through frequent batch auctions and strives to offer zero gas fees for users. Smart contracts are powered by CosmWasm, facilitating seamless multi-chain transactions and enabling complex DeFi applications.

Injective seeks to serve as a foundation for diverse DeFi applications, offering essential infrastructure like an on-chain order book for building decentralized exchanges, prediction markets, and lending protocols. The INJ token is central to the platform, used for protocol governance, securing the network through staking, incentivizing developers, and capturing value from decentralized applications. Injective aims to facilitate a wide range of trading and yield-generating activities, supporting interoperability across multiple layer-one blockchains, including Cosmos and Ethereum, thereby broadening the scope of DeFi opportunities.

Injective was developed by Injective Labs, a research and development firm co-founded by Eric Chen, who brings expertise in blockchain protocols and traditional finance. Albert Chon, the CTO, is a Stanford graduate and former software engineer at Amazon, known for pioneering an Ethereum standard adopted by major projects. The Injective ecosystem aims to encompass over 100 projects and has grown to include more than 150,000 community members worldwide. The project has received backing from various investors, supporting its mission to expand decentralized finance infrastructure.

Atualizamos o nosso Injective para a moeda EUR em tempo real. Obtenha o preço atual de Injective na Coinbase.

A atual capitalização do mercado de Injective é € 429,034 mi. Uma capitalização do mercado elevada implica que um ativo é altamente valorizado pelo mercado.

O maior valor histórico de Injective é € 45,63. Este maior valor histórico é o preço mais alto pago por Injective desde o seu lançamento.

Nas últimas 24 horas, o volume de negociação de Injective foi € 49,837 mi.

Os ativos com uma capitalização do mercado semelhante a Injective incluem Nexo, TrueUSD, SPX6900 e muitos outros. Para ver uma lista completa, consulte os nossos ativos com capitalização do mercado comparável.

A atual oferta em circulação de Injective é 100 milhões.

Injective encontra-se em 87 entre os ativos negociáveis na Coinbase. De momento, a popularidade baseia-se na capitalização do mercado relativa.

De momento, 94% dos utilizadores da Coinbase estão a comprar Injective. Por outras palavras, 94% dos clientes da Coinbase aumentaram a sua posição líquida em Injective nas últimas 24 horas através de negociação.